Raymond James Boosts Monopar Therapeutics (MNPR) PT to $142, Maintains Strong Buy
Monopar Therapeutics Inc. (NASDAQ:MNPR) is one of the best hot stocks to invest in.
Monopar Therapeutics (MNPR)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | RA Capital Management Peter Kolchinsky | 667,207 | $43,568,617 | +31% | 0.45% |
| 2. | Adage Capital Management Phill Gross And Robert Atchinson | 639,467 | $41,757,195 | -3% | 0.06% |
| 3. | Saturn V Capital Management Xiaoying Tian | 325,701 | $21,268,275 | +110% | 3.9% |
| 4. | ADAR1 Capital Management Daniel Schneeberger | 233,908 | $15,274,192 | +80% | 1.12% |
| 5. | Siren L.L.C. Raymond Debbane | 212,298 | $13,863,059 | 0.41% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $69.95 | 1,500 | $104,925.00 | 1,500 | 2025-12-26 | Filing | |
| $16.25 | 1,550 | $25,187.50 | 1,550 | 2024-10-28 | Filing | |
| $0.74 | 20,508 | $15,253.85 | 186,132 | 2024-06-20 | Filing | |
| $0.86 | 12,000 | $10,320.00 | 165,624 | 2024-06-18 | Filing | |
| $0.90 | 12,000 | $10,798.80 | 153,624 | 2024-06-17 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $68.09 | 461 | $31,389.49 | 8,762 | 2025-12-18 | Filing | |
| $67.06 | 4,660 | $312,499.60 | 9,223 | 2025-12-18 | Filing | |
| $63.61 | 550,229 | $34,999,956.64 | 272,026 | 2025-09-24 | Filing | |
| $40.00 | 8,904 | $356,170.68 | 11,486 | 2025-07-14 | Filing | |
| $40.00 | 16,800 | $672,020.16 | 5,173 | 2025-07-14 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 1,317,410 | $85,908,306 | 0.04% | |
| 2. | 293,816 | $19,186,185 | 0% | |
| 3. | 254,857 | $16,642,161 | 0% | |
| 4. | 226,068 | $14,762,241 | 0% | |
| 5. | 141,915 | $9,267,050 | 0.31% |
News See All
12 Best Hot Stocks to Invest In
On September 24, Ryan Detrick, Carson Group chief market strategist, joined CNBC's 'Power Lunch' to discuss why he still expects a strong end-of-year rally.
Chardan Initiates Coverage of Monopar Therapeutics (MNPR) Stock, Gives Buy
Monopar Therapeutics Inc. (NASDAQ:MNPR) is one of the 10 Unstoppable Stocks to Buy According to Hedge Funds.
10 Unstoppable Stocks to Buy According to Hedge Funds
As per Morgan Stanley, investors can see gains in equities and high-quality fixed income for 2025, despite a slowdown in global economic growth. In the Midyear Investment Outlook, Morgan Stanley Research...
Why These 15 Healthcare Stocks Are Surging in 2025
After lagging behind the broader market in 2024, many healthcare stocks are making a comeback this year.
Why These 15 Healthcare Stocks Are Skyrocketing So Far In 2025
The healthcare sector is staging a comeback so far in 2025 after two years of underperformance. These stocks could get even hotter due to AI.
5 Best Rising Penny Stocks To Buy
Monopar Therapeutics (NASDAQ:MNPR) recently jumped after the company reported positive preclinical data for its MNPR-101 program.
5 Hot Penny Stock On the Move
Applied Therapeutics Inc (NASDAQ:APLT) shares jumped about 79% over the past five days through February 22.
Hedge Fund Resource Center Billionaire Hedge Funds
